(Q36808420)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

review article

1 reference

title

Biomarkers for detection and surveillance of bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

0 references

2

Wassim Kassouf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Lorne I Budman

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Jordan R Steinberg

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 June 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

Canadian Urological Association journal

11 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

212-221

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

Clinical model of lifetime cost of treating bladder cancer and associated complications

11 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Economic impact of screening for bladder cancer using bladder tumor markers: a decision analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Urothelial cancer biomarkers for detection and surveillance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

The promising future of proteomics in cancer diagnosis and treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Urine markers for bladder cancer surveillance: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Proteomic approaches in the search for disease biomarkers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Urinary markers of bladder carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Sensitivity and specificity of commonly available bladder tumor markers versus cytology: results of a comprehensive literature review and meta-analyses

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

The ProteinChip Biomarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

The accuracy of urinary cytology in daily practice

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Complement factor H or a related protein is a marker for transitional cell cancer of the bladder.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

The nonchromatin substructures of the nucleus: the ribonucleoprotein (RNP)-containing and RNP-depleted matrices analyzed by sequential fractionation and resinless section electron microscopy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Hematuria screening for bladder cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Can hematuria be a predictor as well as a symptom or sign of bladder cancer?

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Altered extracellular matrices influence cellular processes and nuclear matrix organizations of overlying human bladder urothelial cells.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Identification of a nuclear protein matrix.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Centromeric copy number of chromosome 7 is strongly correlated with tumor grade and labeling index in human bladder cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

A community study of bladder cancer screening by the detection of occult urinary bleeding.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Variability in the performance of nuclear matrix protein 22 for the detection of bladder cancer.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

uCyt+ test: alternative to cystoscopy for less-invasive follow-up of patients with low risk of urothelial carcinoma.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

A side by side comparison of cytology and biomarkers for bladder cancer detection.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Is microscopic haematuria a urological emergency?

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Primary superficial bladder cancer risk groups according to progression, mortality and recurrence.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2494897

Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer

5 September 2018

1 reference

12 December 2020

Validation of the diagnostic value of NMP22 BladderChek test as a marker for bladder cancer by photodynamic diagnosis

1 reference

12 December 2020

Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings

1 reference

12 December 2020

Superficial bladder cancer: progression and recurrence

1 reference

12 December 2020

A study comparing various noninvasive methods of detecting bladder cancer in urine

1 reference

12 December 2020

Detection of bladder cancer using a point-of-care proteomic assay

1 reference

12 December 2020

Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder

1 reference

12 December 2020

Are false-positive urine markers for the detection of bladder carcinoma really wrong or do they predict tumor recurrence?

1 reference

12 December 2020

Surveillance for recurrent bladder cancer using a point-of-care proteomic assay

1 reference

12 December 2020

Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder

1 reference

12 December 2020

A fixed site of DNA replication in eucaryotic cells

1 reference

12 December 2020

Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer

1 reference

12 December 2020

Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation

1 reference

12 December 2020

uCyt+/ImmunoCyt in the detection of recurrent urothelial carcinoma: an update on 1991 analyses

1 reference

12 December 2020

Comparison of seven screening methods in the diagnosis of bladder cancer

1 reference

12 December 2020

Multicolor fluorescence in situ hybridization (M-FISH) on cells from urine for the detection of bladder cancer

1 reference

12 December 2020

Clinical decisions for treatment of different staged bladder cancer based on multitarget fluorescence in situ hybridization assays?

1 reference

12 December 2020

Quantitative molecular urinary cytology by fluorescence in situ hybridization: a tool for tailoring surveillance of patients with superficial bladder cancer?

1 reference

12 December 2020

Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples

1 reference

12 December 2020

Exclusion criteria enhance the specificity and positive predictive value of NMP22 and BTA stat

1 reference

12 December 2020

Newly diagnosed bladder cancer: the relationship of initial symptoms, degree of microhematuria and tumor marker status

1 reference

12 December 2020

Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer

1 reference

12 December 2020

Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt trade mark

1 reference

12 December 2020

Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas

1 reference

12 December 2020

Fluorescence in situ hybridization for detecting transitional cell carcinoma: implications for clinical practice

1 reference

12 December 2020

Effect of intravesical instillations on the human complement factor H related protein (BTA stat) test

1 reference

12 December 2020

Comparisons of voided urine cytology, nuclear matrix protein-22 and bladder tumor associated antigen tests for bladder cancer of geriatric male patients in Taiwan, China

1 reference

12 December 2020

ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma

1 reference

12 December 2020

Qualitative and Quantitative Detection of Urinary Human Complement Factor H-Related Protein (BTA stat and BTA TRAK) and Fragments of Cytokeratins 8, 18 (UBC Rapid and UBC IRMA) as Markers for Transitional Cell Carcinoma of the Bladder

1 reference

12 December 2020

A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma

1 reference

12 December 2020

Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer

1 reference

12 December 2020

Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria

1 reference

12 December 2020

Performance of urine test in patients monitored for recurrence of bladder cancer: a multicenter study in the United States

1 reference

12 December 2020

Natural history and treatment of low and high risk superficial bladder tumors

1 reference

12 December 2020

The value of the ImmunoCyt/uCyt+ test in the detection and follow-up of carcinoma in situ of the urinary bladder

1 reference

12 December 2020

Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization

1 reference

12 December 2020

Application of multiplex FISH, CGH and MSSCP techniques for cytogenetic and molecular analysis of transitional cell carcinoma (TCC) cells in voided urine specimens

1 reference

12 December 2020

Noninvasive detection of bladder cancer with the BTA stat test

1 reference

12 December 2020

Identifiers

DOI

10.5489/CUAJ.600

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18682775%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference